{"pub_date": "2016-06-01T00:00:00Z", "subsection_name": "DealBook", "lead_paragraph": "The deal would further bolster Jazz\u2019s portfolio by acquiring the maker of Vyxeos, a treatment for a form of leukemia.", "print_page": null, "document_type": "article", "byline": {"contributor": "", "person": [{"rank": 1, "organization": "", "lastname": "BRAY", "firstname": "Chad", "role": "reported"}], "original": "By CHAD BRAY"}, "multimedia": [], "section_name": "Business Day", "headline": {"main": "Jazz Pharmaceuticals to Buy Celator for $1.5 Billion"}, "source": "The New York Times", "blog": [], "word_count": "454", "web_url": "http://www.nytimes.com/2016/06/01/business/dealbook/jazz-pharmaceuticals-buy-celator-leukemia.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "The deal would further bolster Jazz\u2019s portfolio by acquiring the maker of Vyxeos, a treatment for a form of leukemia.", "_id": "574d588738f0d826276782e3", "abstract": null, "keywords": [{"rank": "1", "name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N"}, {"rank": "2", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N"}, {"rank": "3", "name": "organizations", "value": "Jazz Pharmaceuticals Inc", "is_major": "N"}]}